Global Borviz 2 (Bortezomib) Exporter from India to Washington, USA, Zimbabwe & New Zealand
City Drug Exporters specializes in exporting Borviz 2 (Bortezomib) from India to international markets including Washington, USA, Zimbabwe, and New Zealand. We provide dependable supply solutions for pharmaceutical wholesalers, distributors, pharmacies, and healthcare procurement companies.
Borviz 2 (Bortezomib) is a targeted chemotherapy medication primarily used to treat blood cancers, specifically multiple myeloma (cancer of the bone marrow plasma cells) and mantle cell lymphoma (a rare cancer affecting lymph nodes). It acts as a proteasome inhibitor to disrupt cancer cell growth and cause cell death.
Key Therapeutic Uses :
Multiple Myeloma: Used in newly diagnosed patients, as maintenance therapy, or for relapsed cases to reduce tumor burden, prevent bone destruction, and enhance the effectiveness of combination cancer therapies.
Mantle Cell Lymphoma: Prescribed for adult patients whose disease has returned or who have already received at least one prior therapy.
Combination Therapy: Depending on the cancer stage and patient profile, it is often administered alongside other medications like dexamethasone, thalidomide, melphalan, or rituximab.
City Drug House Exporters provides:
Bulk supply for hospitals & distributors
Export to USA. Washington, INDIA
Regulatory documents (COA, MSDS, etc.)
Competitive pricing & reliable logistics
Contact for More Information :
π Contact City drug House Exporters from India
π Websites:
https://www.citydrugexporters.com
π§ Email: citydrug123@gmail.com
π¦ Business Type: Exporter | Bulk Supplier | Distributor
π² WhatsApp: +91 9975390171
